These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9690411)

  • 21. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
    MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
    Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance.
    Bart BA
    Am Heart J; 1999 Nov; 138(5 Pt 1):801-3. PubMed ID: 10539807
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A.
    Schmaldienst S; Winkler S; Breiteneder S; Hörl WH
    Nephrol Dial Transplant; 1997 Apr; 12(4):790-2. PubMed ID: 9141015
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A
    Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F; Khankin E; Yaccob A; Kawachi H; Karram T; Awaad H; Nakhoul N; Hoffman A; Abassi Z
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of enalapril in mild to moderate hypertension.
    Sharma S; Gupta U; Bapna JS; Sahai A
    J Assoc Physicians India; 1995 Jul; 43(7):475-6. PubMed ID: 8713222
    [No Abstract]   [Full Text] [Related]  

  • 28. Lisinopril--another ACE inhibitor.
    Drug Ther Bull; 1989 Apr; 27(8):31-2. PubMed ID: 2562398
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe chemosis in a patient with nephrotic syndrome.
    Jankauskiene A; Buteikiene I
    Eur J Pediatr; 2009 Apr; 168(4):507-8. PubMed ID: 18661147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Converting enzyme inhibition and left ventricular hypertrophy.
    Fagard R
    Eur Heart J; 1995 Dec; 16(12):1748-9. PubMed ID: 8681996
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors slow recovery from anemia following cardiac surgery.
    Ripamonti V; Racca V; Calvo MG; Castiglioni P; Ferratini M
    Chest; 2006 Jul; 130(1):79-84. PubMed ID: 16840386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J
    Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome.
    Bruno I; Pennesi M; Marchetti F
    Pediatr Nephrol; 2003 Dec; 18(12):1293-4. PubMed ID: 14579142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M; Colazo A; Vallejo G; Zotta E
    Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 36166246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to treat heart failure.
    Lancet; 1992 Feb; 339(8788):278-9. PubMed ID: 1346289
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease.
    Watanabe Y; Fukuzawa Y; Inaguma D
    Clin Nephrol; 1996 May; 45(5):362-3. PubMed ID: 8738675
    [No Abstract]   [Full Text] [Related]  

  • 38. Enalapril-induced anemia in two kidney transplant recipients.
    Graafland AD; Doorenbos CJ; van Saase JC
    Transpl Int; 1992 Mar; 5(1):51-3. PubMed ID: 1580986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitors improve compliance.
    Gever LN
    Nursing; 1987 Oct; 17(10):143. PubMed ID: 2821461
    [No Abstract]   [Full Text] [Related]  

  • 40. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.